Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Prasterone

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 268Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Theramex Australia Enters Partnership With Endoceutics For Intrarosa
    Theramex Australia Enters Partnership With Endoceutics For Intrarosa

    14 Feb 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220214005409/en

    BUSINESSWIRE
    14 Feb 2022
    Share Share
    AMAG Completes Sale of its Rights to Intrarosa® to Millicent for up to $125M
    AMAG Completes Sale of its Rights to Intrarosa® to Millicent for up to $125M

    21 May 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/05/21/2037319/0/en/AMAG-Pharmaceuticals-Completes-Sale-of-its-Rights-to-Intrarosa-to-Millicent-Pharma-for-up-to-125-Million.html

    GLOBENEWSWIRE
    21 May 2020
    Share Share
    Amag to divest two of three women's health drugs, CEO to step down
    Amag to divest two of three women's health drugs, CEO to step down

    10 Jan 2020

    // Manas Mishra REUTERS

    https://www.reuters.com/article/us-amag-divestiture/amag-pharmaceuticals-to-divest-two-womens-health-drugs-ceo-to-step-down-idUSKBN1Z81JX?feedType=RSS&feedName=healthNews

    Manas Mishra REUTERS
    10 Jan 2020
    Share Share
    Mundipharma & Endoceutics to Exclusively License Intrarosa™ in MEA Region
    Mundipharma & Endoceutics to Exclusively License Intrarosa™ in MEA Region

    21 May 2018

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/mundipharma-and-endoceutics-to-exclusively-license-intrarosa-prasterone-in-mea-region-683140131.html

    PR NEWSWIRE
    21 May 2018
    Share Share
    Endoceutics Intrarosa (Prasterone) Receives Approval in Europe
    Endoceutics Intrarosa (Prasterone) Receives Approval in Europe

    15 Feb 2018

    // EMA

    https://www.pharmacompass.com/pdf/news/endoceutics-intrarosa-prasterone-receives-approval-in-europe-1518673798.pdf

    EMA
    15 Feb 2018
    Share Share
    Ten medicines recommended for approval, including two orphan
    Ten medicines recommended for approval, including two orphan

    11 Nov 2017

    // EMA

    http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2017/11/news_detail_002844.jsp&mid=WC0b01ac058004d5c1

    EMA
    11 Nov 2017
    Share Share